This review article shares insights from a virtual symposium that took place at the European School of Haematology (ESH) 7th Translational Research e-Conference: Myelodysplastic Syndromes. The three leading speakers have provided a summary of presentations on myelodysplastic syndrome (MDS) treatment, with a focus on precision medicine, the immune and inflammatory microenvironments, and therapies for high-risk cases.
EMJ Hematology 9 [Supplement 2] . 2021
May 2021
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/07/Filgrastim-Prophylaxis-for-Neutropenia-in-Myelodysplasia-Pre-Surgery-Case-Report-Web-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/Diffuse-Large-B-Cell-Lymphoma-of-Spleen-A-Key-Differential-of-Nodular-Splenomegaly-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/The-Impact-of-‘Pre-conception-on-Conception-An-Inadvertent-Form-of-Infertility-Web-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/Hema_Article_Waheed-940x564.jpg)